Loading clinical trials...
Loading clinical trials...
Multicenter, Double-blind, Randomized, Parallel Group Study to Evaluate the Immunogenicity, Reactogenicity and Safety of the Grippol® Quadrivalent Vaccine in Children Aged 6 Months to 5 Years (Inclusive)
Conditions
Interventions
Grippol Quadrivalent
Grippol Plus
Locations
14
Russia
Federal State Budgetary Research Institution "Russian research center of surgery named after academician B.V. Petrovsky"
Moscow, Russia
State Budgetary Healthcare Institution "Children's City Clinical Hospital No.9 named after G.N. Speransky of Moscow Healthcare Department"
Moscow, Russia
State Budgetary Health Institution of the Perm Territory "City Children's Clinical Polyclinic No. 5
Perm, Russia
Limited Liability Company "Clinic USI 4D"
Pyatigorsk, Russia
Limited Liability Company Medical technology
Saint Petersburg, Russia
St. Petersburg State Budgetary Health Institution "Children's City Polyclinic No. 45 of the Nevsky District"
Saint Petersburg, Russia
Start Date
September 21, 2022
Primary Completion Date
June 15, 2023
Completion Date
October 9, 2023
Last Updated
April 26, 2024
NCT01386424
NCT07169318
NCT07291635
NCT06599658
NCT06094010
NCT06753474
Lead Sponsor
NPO Petrovax
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions